Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

FRX

Ferrex (FRX)

Ferrex
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:FRX
FechaHoraFuenteTítuloSímboloCompañía
19/07/202206:30RNS Non-RegulatoryKeras Resources PLC Update regarding Investor Presentation and GMLSE:FRXFerrex
22/06/202209:20RNS Non-RegulatoryKeras Resources PLC New Date - Shareholder/Investor PresentationLSE:FRXFerrex
09/06/202201:03RNS Non-RegulatoryKeras Resources PLC Shareholder/Investor Meeting and PresentationLSE:FRXFerrex
24/06/202108:36RNS Non-RegulatoryKeras Resources PLC Updated Corporate PresentationLSE:FRXFerrex
30/10/201902:00RNS Non-RegulatoryKeras Resources PLC Joint Investor Event - Further DetailsLSE:FRXFerrex
14/09/201806:00RNS Non-RegulatoryKeras Resources PLC Investor EventLSE:FRXFerrex
23/11/201709:55RNS Non-RegulatoryKeras Resources PLC New Company PresentationLSE:FRXFerrex
16/11/201703:47RNS Non-RegulatoryKeras Resources PLC Pilbara Gold Presentation-London 23 November 2017LSE:FRXFerrex
01/08/201701:02RNS Non-RegulatoryKeras Resources PLC Brandon Hill ResearchLSE:FRXFerrex
12/04/201606:20RNS Non-RegulatoryKeras Resources PLC New Corporate PresentationLSE:FRXFerrex
18/03/201602:00RNS Non-RegulatoryKeras Resources PLC Corporate PresentationLSE:FRXFerrex
29/10/200904:54Dow Jones NewsRichter To Start Late Stage Tests On Key Schizophrenia DrugNYSE:FRXForest Laboratories Inc.
29/10/200903:47Dow Jones NewsHungary Richter, US Forest Announce Positive Drug TestsNYSE:FRXForest Laboratories Inc.
27/08/200917:31PR Newswire (US)Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and ReduceNYSE:FRX
19/08/200908:50Dow Jones News2nd UPDATE: Glenmark, Forest Say Their Drug Failed In TrialsNYSE:FRXForest Laboratories Inc.
19/08/200902:53Dow Jones NewsUPDATE: Glenmark, Forest Say Oglemilast Failed In Key StudyNYSE:FRXForest Laboratories Inc.
12/08/200903:32Dow Jones NewsAstraZeneca, Forest Labs Ink Ceftaroline DealNYSE:FRXForest Laboratories Inc.
10/08/200906:00PR Newswire (US)Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPDNYSE:FRX
21/07/200908:08Dow Jones NewsForest Labs 1Q Net Up 8.2% As Namenda Sales JumpNYSE:FRXForest Laboratories Inc.
22/06/200908:20PR Newswire (US)Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and WyndhamNYSE:FRX
19/06/200913:40Dow Jones NewsForest Labs Reports Upbeat Pneumonia Drug Test ResultsNYSE:FRXForest Laboratories Inc.
10/06/200909:54Dow Jones NewsPHARMA MARKET: Wyeth Stands By Pristiq After Slow StartNYSE:FRXForest Laboratories Inc.
22/05/200915:34Dow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsNYSE:FRXForest Laboratories Inc.
05/05/200910:03Dow Jones News2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZenecaNYSE:FRXForest Laboratories Inc.
30/04/200903:01Dow Jones NewsAlmirall, Forest See New Drug Application For COPD By 2012NYSE:FRXForest Laboratories Inc.
21/04/200908:09Dow Jones NewsForest Labs 4Q Net Drops 46% Amid Marketing Probe Set-AsideNYSE:FRXForest Laboratories Inc.
03/04/200918:34Dow Jones NewsUPDATE: FDA Warns World's Largest Drug Firms Over Internet AdsNYSE:FRXForest Laboratories Inc.
03/04/200917:22Dow Jones NewsFDA Warns World's Largest Drug Firms Over Internet AdsNYSE:FRXForest Laboratories Inc.
06/03/200906:21Dow Jones NewsFDA Wants More Study On Almirall, Forest Labs COPD DrugNYSE:FRXForest Laboratories Inc.
25/02/200916:24Dow Jones NewsUPDATE:DOJ:Forest Labs Engaged In Improper Marketing,KickbacksNYSE:FRXForest Laboratories Inc.
 Showing the most relevant articles for your search:LSE:FRX